# Randomized Clinical Investigation of Photobiomodulation (PBM) for the Management of Early Peripheral Neuropathy Related to Medical Oncologic Therapy

> **NCT07681921** · NA · NOT_YET_RECRUITING · sponsor: **Jules Bordet Institute** · enrollment: 98 (estimated)

## Conditions studied

- Chemotherapy Induced Peripheral Neuropathy

## Interventions

- **DEVICE:** Photobiomodulation

## Key facts

- **NCT ID:** NCT07681921
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681921, "Randomized Clinical Investigation of Photobiomodulation (PBM) for the Management of Early Peripheral Neuropathy Related to Medical Oncologic Therapy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07681921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*